Laddar...
PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by the deposition of β-amyloid within the brain parenchyma and is accompanied by the impairment of neuronal metabolism and function, leading to extensive neuronal loss. The disease involves the perturbation of synaptic function, energy, and lipid metabolism....
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer-Verlag
2008
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2593876/ https://ncbi.nlm.nih.gov/pubmed/18625459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.05.003 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|